Concepedia
Statistics
Publications
8
Citations
153
H-Index
Active since
2005
Affiliations
US Biotest (United States)(Current)
University of Southern California
Applied Nanotech (United States)
Keck Hospital of USC
Holly Maulhardt is an author at US Biotest (United States) specializing in nanomedicine, oncology, and cancer nanomedicine.
Publications per year
2005–2023
A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies
Stephen K. Williamson, Gary A. Johnson, Holly Maulhardt et al. · Cancer Chemotherapy and Pharmacology · 2015 · 66 citations · Full text
Pharmacy, Pharmaceutics, Pharmacology +13
Local Injection of Submicron Particle Docetaxel is Associated with Tumor Eradication, Reduced Systemic Toxicity and an Immunologic Response in Uro-Oncologic Xenografts
Holly Maulhardt, Lauren Hylle, Michael Frost et al. · Cancers · 2019 · 17 citations · Full text
Medicine, Oncology, Pharmacology +17
Development of a guinea pig cutaneous radiation injury model using low penetrating X-rays
Kathleen E. Rodgers, Alick Tan, Lila Kim et al. · International Journal of Radiation Biology · 2016 · 15 citations
Medicine, Dermatology, Radiation Dosimetry +16
Fragments of Nle<sup>3</sup>‐angiotensin(1–7) accelerate healing in dermal models
Kathleen E. Rodgers, Dolph D. Ellefson, Theresa Espinoza et al. · Journal of Peptide Research · 2005 · 13 citations · Full text
Life Sciences, Biochemistry, Pathobiology +14
Response of Locally Advanced Pancreatic Cancer to Intratumoral Injection of Large Surface Area Microparticle Paclitaxel
Neil Sharma, Simon K. Lo, Andrew Hendifar et al. · Pancreas · 2023 · 12 citations · Full text
1–5 of 8